preliminary chapters Flashcards
Drugs interacting with grapefruit juice
enzyme INHIBITOR
CVS: SCAR
- statins
- ccbs
- amiodarone/dronedarone
- ranolazine
CNS
- quetiapine
- sertraline
Immunosuppressants
- tacrolimus
- ciclosporin
OTHER:
- colchicine
- pd5i i.e. sildenafil
How many half lives before a drug reaches steady state
x5
Signs of nephrotoxicity
reduced urine output odema dehydration NAV fatigue hypertension confusion backache
Nephrotoxic drugs
5A - aminoglycosides, aminosalicylates, ACEi, aciclovir, amphotericin B
3C - cyclophosphamide, ceph, ciclosporin
2T - tetracyclines, tacrolimus
LMNQV - lithium, MTX, NSAIDS, quinolones, vancomycin
risk factor for AKI
dehydration
meds to stop during illnesses resulting in dehydration (vom, diarrhoea, fever, sweats)
DAMN
- diuretics (dehyd and electrolyte disturbances)
- ACEi (reduce egfr + nephrotoxic)
- metformin (increased LA risk in RI)
- NSAIDS (nephrotoxic, reduce eGFR, water and sodium retention)
when to restart sick day meds
24-48hrs after normal eating and drinking
drugs that stain urine red
dantron (co-danthrusate) doxorubicin levodopa (body secretions)
drugs that stain urine red-orange
rifampicin (body secretions)
drugs that stain urine orange
sulfasalazine (body secretions)
drugs that stain urine yellow-brown
nitrofurantoin
senna
drugs that stain urine pink-orange
phenindione
drugs that stain urine blue
triamterene
drugs that stain urine/stools black/tarry
iron
bismuth
drugs that stain urine brown
PG analogues e.e. latanoprost can cause brown pigmentation of iris
analgesic of choice in palliative care
morphine
ALT: oxy stronger - hydromorphone/methadone patches - fentanyl/bup parenteral - diamorphine
breakthrough pain
1/6-1/10 of total daily dose every 2-4 hours prn
PO to Parenteral (IV/IM/SC)
half dose of oral morphine
diamorphine is equivalent to
third of oral dose of morphine
why is diamorphine preferred over morphine for the parenteral route
more soluble = large dose in small volume
when switching to patches due to hyperalgesia, reduce opioid dose by
25-50%
Managing opioid induced constipation
-faecal softener + stimulant
senna + lactulose or co-danthramer/danthrusate
methylnaltrexone
methylnaltrexone drug class
opioid receptor antagonist
Managing opioid induced NAV
metoclopramide
haloperidol
MAX 4-5 days
Managing opioid induced dry mouth
- good oral hygiene
- artificial saliva
Managing opioid induced dry mouth CANDIDIASIS
nystatin
oral miconazole
fluconazole
Treating neuropathic pain
TCAD
Anti epi
ketamine last resort - under supervision
Treating pain due to nerve compression
Dexamethasone
Treating bone metastases
radiotherapy
bisphosphonate
strontium ranelate
Treating anorexia
Prednisolone/dexamethasone increases appetite/weight gain
Treating secretions
SC hyoscine/glycopyrronium
Treating bowel colic
loperamide
Treating capillary bleeding
tranexamic acid (antifibrinolytic) adrenaline vit K in prolonged clotting in liver disease
Treating convulsions due to uraemia/cerebral tumour
phenytoin
CBZ
SC midazolam
Treating dysphagia due to tumour obstruction
dexamethasone
Treating fungating tumours
metronidazole
Treating dyspnoea
PO morphine (reduces respiratory drive to relieve breathlessness)
w/ anxiety - diazepam
bronchospasm/obstruction - corticosteroids
Treating gastric distension
antacid + antiflatulent + prokinetic (i.e. domperidone before meals)
Treating hiccup due to gastric distension
antacid + antiflatulent
FAILURE
+metoclopramide
Treating insomnia
BDZ
Treating intractable coughs
moist inhalation
PO morphine
AVOID methadone linctus as it can accumulate
Treating muscle spasms
diazepam
baclofen
Treating NAV
first line in advanced cancer:
prokinetic antiemetic
Haloperidol Levomepromazine Cyclizine Metoclopramide Dexamethasone
Treating pruritis
Emollients
Treating obstructive cholestatic jaundice
colestyramine
Treating headache due to raised intracranial pressure
dexamethasone
Treating restlessness/confusion
haloperidol
levomepromazine
what long acting SU should be avoided in 65+
glibenclamide
Treating gravitational oedema in elderly
AVOID DIURETICS
raise/move legs or wear stockings
Maintenance dose of digoxin in elderly
125mcg daily
62.5mcg in renal disease
Reporting ADR
YELLOW CARD SCHEME
When to report ADR
- Newer drugs/vaccines (upside down triangle for 5 years)
- Medication errors (also to national reporting learning system)
- Medical devices e.g. IUD, contact lens fluid, dental or surgical materials
- Defective medicines/Fake meds - report to defective medicines report centre division of MHRA
onset of anaphylaxis
<1 hour after drug exposure
onset of cutaneous reaction to drug
non immediate without systemic involvement
6-10 days after 1st exposure
OR 3 days after 2nd exposure
onset of non immediate reactions WITH systemic involvement
3days - 6 weeks after first exposure
nature of non immediate reactions WITH systemic involvement
- cutaneous reactions with systemic features
- toxic epidermal necrolysis/SJS
- acute generalised exanthematosous pustulosis
nature of cutaneous reaction to drug
widespread red macules +/or papules OR localised inflamed skin
drugs causing oral ulcers
ACEi NSAID Nicorandil Pancreatin Cytoxics (MTX)
drugs causing oral candidiasis
cortocosteroids
drugs causing brown staining of teeth
chlorhexidine
drugs causing black staining of teeth
liquid iron
drugs causing yellow/grey staining of teeth
tetracyclines
drugs causing osteonecrosis of jaw
bisphosphonates
drugs causing gingival hypertrophy
ciclosporin
nifedipine
phenytoin
drugs causing dry mouth
AMs APs AHs ADs opioids diuretics
drugs causing taste disturbances
ACEi amiodarone carbimazole clarithromycin Lithium Metformin Metronidazole Zopiclone
Drugs causing blood dyscrasias
DMARDs
AEs - CBZ/Ethosux/Phenytoin/Lamotrigine
ABs - trimethoprim/dapsone/chloramphenicol/linezolid
Immunosuppressants
Antifolates - MTX/trimethoprim/phenytoin
Aminosalicylates/carbimazole/clozapine/mirtazepine
Drugs causing photosensitivity
Antifungals - voriconazole
Tetracyclines
Selphonamide
Quinolones
Hydroxychlorophine
Amiodarone
Phenothiazines
Tacrolimus
Topical NSAIDs
Benzoyl peroxide
Isotretinoin
Vitamin A
Drugs causing contact sensitisation
MTX
Chlorpromazine
Cytotoxics
Drugs causing QT prolongation
APs - Pimozide/Halo/Quet
ADs - SSRIs(cit/escit), TCADs, Vanlaflaxine
Sotalol/Ami
CNS - methadone, Li, 5HT1aA, 5HT3A, domp, meto, quinine
Macrolides, Hydroxychloroquine, quinolones, -conazoles
Risk factors for QT prolongation
Age Female Cardiac disease Bradycardia HypoK, HypoMg, HypoCa
Drugs causing hypokalaemia
Loop/Thiazide diuretics Corticosteroids Beta2Ag Theophylline Stimulant lax Amphoteracin B
Drugs causing bradycardia
BB Amiodarone RLCCBs Digoxin Clonidine AMs TCADs AChEi
Drugs causing antimusc effects
AMs TCADs AHs APs Atropine & Clozapine
Drugs causing peripheral neuropathy
Amiodarone
Phenytoin
Isoniazid
Metronidazole
Drugs causing serotonin syndrome
5Ht1A Agonists e.g. sumatriptan 5HT3A e.g. granisetron ADs - TCADS/MOAi/SSRI MAOBi - selegiline SJW
Drugs causing ototoxicity
Aminoglycosides
Glycopeptides
Loop diuretics
Drugs causing lower seizure threshold
Quinolones Mefloquine SSRIs APs Tramadol Theophylline Lithium Baclofen Amphetamines
Drugs causing increased potassium
ACEi/ARB Aldosterone antag e.g. spir NSAIDS Tacrolimus Triamterene Trimethoprim
Drugs causing reduced potassium
Theophylline Amphoteracin B B2 ag Corticosteroidse Diuretics Stimulant laxatives
Drugs causing hyponatraemia
CBZ diuretics ADs NSAIDs Desmopressin
Risk of taking teratogenic drugs in 1st trimester
Teratogenicity occurs in first trimester
Congenital abnormalities
Risk of taking certain drugs in 2nd/3rd trimester
growth & development
Risk of taking certain drugs at term
obstetric complications and effects on the baby
Teratogenic drugs
Antifolates - MTX & trimeth
Statins
Tetracyclines
PGA - misoprosol
ACEi/ARB
Isotretinoin
Lithim
Valproate
Warfarin - congenital malformations, fetal and nneonatal haemorrhage
Chloramphenicol
Aspirin/NSAIDs - early closure of ductus arteriosus
Topiramate (cleft palate)
Finasteride v(feminisation of male fetus)
Quinolones (arthropathy)
Aminoglycosides (auditory and vestibular damage in 2/3 trimester)
Drugs affecting breast feeding
High amounts in breast milk:
ethosuximide
lamotrigine
fluvastatin
Inhibiting sucking reflex:
phenobarbital
Inhibiting lactation
bromocriptine
preterm neonate
born <37 weeks
term neonate
born 37 weeks-42 weeks
post-term neonate
born >42 weeks
Neonate
0-28 days
infant
28 days-24 months
child
2-12 years
adolescent
12-18 years
Dosing in overweight children
use ideal body weight
neonate eGFR
30xheight / serum creatinine
> 1 year eGFR
40xH / serum creatinine
unlicensed
no license in UK
no MA
off label
licensed in UK but outside MA
What injection route should be avoided in children
IM - painful
Which injection excipient should be avoided in children
benzyl alcohol
benzyl alcohol excipient side effect
fatal toxic syndrome
what excipient should nbe avoided in renal failure
propylene glycol
freshly prepared
<24 hours before use
recently prepared
4 weeks expiry when stored 15-25 degrees
biologic
derived from biological source using biotechnology e.g. MAB/insulin
biosimilar
similar to existing originator biologic
active substance is similar and clinically equivalent
Not the same as a generic
e.g. absalgar (biosimilar of insuline glargine)
prescribe by brand name
contraindications to SC route
prochlorperazine
chlorpromazine
diazepam
injection site reactions
Injections dissolved in WFI
hypotonic = more pain
lower osmotic pressure than blood
injections dissolved in physiological saline
NaCl 0.9% isotonic - more similar osmotic pressure to blood
increased precipitation when given with more than one drug
drugs compatible with diamorphine
cyclizine <10ml/ml <24hrs - avoid precip
haloperidol <2ml/ml <24hrs - avoid precip
Dexamethasone hyoscine levomepromazine metoclopramide midazolam
when to discontinue infusion
<24 hrs
cloudiness
crystallisation
change of colour
sign of interaction/contamination
In an IV infusion, what must you not add drugs to
blood products
mannitol
sodium bicarb
Excipients that give rise to incompatibility in infusions
amino acids
mannitol
sodium bicarb
significant loss of potency of drugs occurs in infusions when
when added to large volume infusions
undesirable to mix BL-ABs with what and why?
proteinaceous materials
immunogenic and allergenic conjugates may form
What must you not add to IV fat emulsions
ABs & electrolytes
coalescence of fat globules
separation of phases
= increased possibility of embolism
the acceptable limit for admixtures where degradation occurs without forming toxic substances
time taken for 10% decomp
from addition to admin to guarantee good drug potency and compatibility
what injections must be protected from light
dacarbazine
sodium nitroprusside
minimise oxidation
continuous infusion
diluted in large volume over long time
intermittent infusion
diluted in small volume over short time
intermittent infusion uses
incompatible/stable products over time e.g. ampicillin/amoxx
When are drip tubes used for addition of drugs
for cytotoxic drugs
minimise extravasion
hypoproteinaemia
reduced protein binding = more free drug = toxicity
warfarin
phenytoin
NSAIDS
prednisolone
malabsorption of fat soluble vits
ADEK
vit K deficiency
increased risk of bleeding
Menadiol
water soluble vit k analogue used in fat malabsorption diseases
reduced bile excretion
intrahepatic/extrahepatic obstructive jaundice
fusidic acid and rifampicin accumulate as they are excreted in bile acid
prescribing in liver impairment
impaired drug metab - reduce dose
hypoproteinaemia
reduced blood clotting
malabsorption of fat sol vits
reduced bile excretion
hepatic encephalopathy
constipating drugs e.g. opioids/TCADs
sedatives e.g. opioids/AHs/BDZ/Z drugs
drugs causing hypocalaemia e.g. loop/thiazide diuretics
hepatic encephalopathy treatment
lactulose
what drugs exacerbate oedema and ascites in liver disease
NSAIDs
corticosteroids
hepatotoxic drugs
APs amiodarone cbz co-amox cyproterone dantrolene fluconazole flucloxacillin isoniazid itraconazole ketoconazole labetolol leflunamide MTX paracetamol phenothiazine pioglitazone rifampicin statins tetracyclines valproate zafirlukast
signs of hepatotoxicity
jaundice
ab pain
NAV
malaise
weight loss
pruritus
dark urine
pale stools
drowsy/confusion
enzyme inhibitors
SICKFACES.COM
sodium valproate isoniazid cimetidine ketoconazole fluconazole alcohol chloramphenicol erythromycin sulphonamide ciprofloxacin omeprazole metronidazole
enzyme inducers
BS CRAP GPS
barbiturates
SJW
CBZ
rifampicin
alcohol
phenytoin
griseofulvin
phenobarbital
sulphonylureas